NBD is a spin-off company with three areas of focus : Drug Discovery, Enzyme Engineering and Nucleic Acids.
In particular, we have developed strong (international-level) expertise in early stage Drug Discovery and Enzyme/Protein Engineering (including in-silico Direct Evolution, and Antibody Design/Optimization).
We provide customer-tailored solutions based on our state-of-the-art proprietary and top-of-the-line 3rd parties software (including Schrodinger suite), combined with the latest development on AI. We use best in-class Molecular Modelling for data augmentation and fine-tuning of dedicated machine-learning algorithms; as an example, to reinforce the discriminating neural network in a generative model (both for proteins and small molecules).
|Access Date||Quiz Result||Score||Actions|